Trulieve Cannabis Corp. (CSE:TRUL)
12.07
-0.53 (-4.21%)
At close: Jan 13, 2026
Trulieve Cannabis Employees
Trulieve Cannabis had 6,000 employees as of December 31, 2024. The number of employees increased by 600 or 11.11% compared to the previous year.
Employees
6,000
Change (1Y)
600
Growth (1Y)
11.11%
Revenue / Employee
276.07K CAD
Profits / Employee
-28.85K CAD
Market Cap
2.13B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 6,000 | 600 | 11.11% |
| Dec 31, 2023 | 5,400 | -2,200 | -28.95% |
| Dec 31, 2022 | 7,600 | -1,400 | -15.56% |
| Dec 31, 2021 | 9,000 | 4,155 | 85.76% |
| Dec 31, 2020 | 4,845 | 1,761 | 57.10% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Extendicare | 23,000 |
| Sienna Senior Living | 12,263 |
| dentalcorp Holdings | 10,200 |
| Curaleaf Holdings | 5,519 |
| Green Thumb Industries | 4,800 |
| Verano Holdings | 3,800 |
| WELL Health Technologies | 1,507 |
| Vireo Growth | 520 |
Trulieve Cannabis News
- 1 day ago - 3 Top Marijuana Stocks For Investors Looking To Take Part In The Green Rush - MarijuanaStocks
- 3 days ago - Top Cannabis Stocks in the U.S. Heading Into January 2026 - MarijuanaStocks
- 5 days ago - Top 3 U.S. Marijuana Stocks to Watch in January 2026 - MarijuanaStocks
- 9 days ago - 5 Predictions for the Stock Market in 2026 -- and Which Stocks Will Soar the Most If They're Right - The Motley Fool
- 11 days ago - Top Marijuana Stocks To Buy In 2026 That Could See Big Gains - MarijuanaStocks
- 18 days ago - 3 Marijuana Stocks To Watch In 2026 - MarijuanaStocks
- 21 days ago - President Trump Just Reclassified Marijuana. Are Green Thumb, Tilray, and Trulieve Stocks No-Brainer Buys? - The Motley Fool
- 22 days ago - President Donald Trump Just Fast-Tracked the Rescheduling of Marijuana, and Pot Stocks Plunged -- Here's the Nefarious Reason Why - The Motley Fool